Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lepob/Lepob mice
暂无分享,去创建一个
M. Stock | C. Wilson | Y. L. Liu | I. Connoley | Y L Liu | I. Connoley | C A Wilson | M J Stock
[1] Pierre Casellas,et al. Hypersensitization of the Orexin 1 Receptor by the CB1 Receptor , 2003, Journal of Biological Chemistry.
[2] P. Soubrié,et al. The cannabinoid CB1 receptor antagonist SR141716 increases Acrp30 mRNA expression in adipose tissue of obese fa/fa rats and in cultured adipocyte cells. , 2003, Molecular pharmacology.
[3] G. Kennett,et al. Preferential effects of the cannabinoid CB1 receptor antagonist, SR 141716, on food intake and body weight gain of obese (fa/fa) compared to lean Zucker rats , 2003, Psychopharmacology.
[4] P. Soubrié,et al. Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice. , 2003, American journal of physiology. Regulatory, integrative and comparative physiology.
[5] B. Levin,et al. Reduced central leptin sensitivity in rats with diet-induced obesity. , 2002, American journal of physiology. Regulatory, integrative and comparative physiology.
[6] M. Stock,et al. Comparison of the thermogenic and hypophagic effects of sibutramine's metabolite 2 and other monoamine reuptake inhibitors. , 2002, European Journal of Pharmacology.
[7] Jesús García,et al. Dissociation of charge movement from calcium release and calcium current in skeletal myotubes by gabapentin. , 2002, American journal of physiology. Cell physiology.
[8] V. Marzo,et al. Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2‐arachidonoyl glycerol , 2002, British journal of pharmacology.
[9] N. Jamshidi,et al. Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats , 2001, British journal of pharmacology.
[10] K. Perry,et al. The cannabinoid CB(1) receptor antagonist SR141716A increases norepinephrine outflow in the rat anterior hypothalamus. , 2001, European journal of pharmacology.
[11] R. Palmiter,et al. Leptin-regulated endocannabinoids are involved in maintaining food intake , 2001, Nature.
[12] H. Lodish,et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[13] M. Cawthorne,et al. BRL37344, but not CGP12177, stimulates fuel oxidation by soleus muscle in vitro. , 2000, European journal of pharmacology.
[14] F. Casanueva,et al. Leptin regulation of prepro-orexin and orexin receptor mRNA levels in the hypothalamus. , 2000, Biochemical and biophysical research communications.
[15] T. Kirkham,et al. Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors , 1999, Psychopharmacology.
[16] M. Stock,et al. Thermogenic effects of sibutramine and its metabolites , 1999, British journal of pharmacology.
[17] S. Bloom,et al. A C-terminal fragment of Agouti-related protein increases feeding and antagonizes the effect of alpha-melanocyte stimulating hormone in vivo. , 1998, Endocrinology.
[18] A. Sahu. Evidence suggesting that galanin (GAL), melanin-concentrating hormone (MCH), neurotensin (NT), proopiomelanocortin (POMC) and neuropeptide Y (NPY) are targets of leptin signaling in the hypothalamus. , 1998, Endocrinology.
[19] C. Strader,et al. Diet-induced obese mice develop peripheral, but not central, resistance to leptin. , 1997, The Journal of clinical investigation.
[20] R. Palmiter,et al. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y , 1996, Nature.
[21] M. Cawthorne,et al. Biphasic effects of the β‐adrenoceptor agonist, BRL 37344, on glucose utilization in rat isolated skeletal muscle , 1996, British journal of pharmacology.
[22] P. Soubrié,et al. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor , 1994, FEBS letters.
[23] T. Issad,et al. Effects of fasting on tissue glucose utilization in conscious resting rats. Major glucose-sparing effect in working muscles. , 1987, The Biochemical journal.
[24] E. Newsholme,et al. Sensitivity to insulin of glycolysis and glycogen synthesis of isolated soleus-muscle strips from sedentary, exercised and exercise-trained rats. , 1983, The Biochemical journal.
[25] M. Stock. An automatic, closed-circuit oxygen consumption apparatus for small animals. , 1975, Journal of applied physiology.